盘前异动 | 百济神州跌超6%，再遭艾伯维起诉剽窃商业机密
本周四（9月12日）， 百济神州 盘前跌超6%，截至发稿报197.49美元，跌幅6.47%：
据海外医药行业媒体Fierce Biotech报道，跨国药企 艾伯维公司 （AbbVie）近期再次起诉了百济神州，理由是后者剽窃了其BTK降解剂（BTK degrader）的商业秘密。
百济神州方面则表示，已获悉艾伯维近期向本公司提起一项诉讼，诉讼包含百济神州自主发现的化合物BGB-16673。百济神州将对艾伯维发起的指控开展坚决辩护，公司目前在仔细核阅艾伯维的控诉，并将通过法律程序做出适当回应。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10